Skip to content
lifestyle.onlygolfnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Norroy Bioscience Co., Ltd.
NORROY BIOSCIENCE Showcased 11 Research Presentations at EANM’ 26, Advancing Radiopharmaceutical Innovation and Global Ecosystem Collaboration
November 5, 2026
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
September 2, 2026
NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product
August 19, 2026